Peregrine Pharmaceuticals reported $24.31M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acceleron Pharma XLRN:US $ 27.94M 2.73M
Adamas Pharmaceuticals ADMS:US 10.1M 2.32M
Agenus AGEN:US $ 1.44M 0.74M
Amgen AMGN:US $ 4479M 56M
AstraZeneca AZN:LN 6.84B 214M
Biocryst Pharmaceuticals BCRX:US $ 27.62M 9.23M
Bristol Myers Squibb BMY:US $ 11275M 2615M
Celldex Therapeutics CLDX:US $ 0.5M 1.33M
Chemocentryx CCXI:US $ 0.17M 9.97M
Dicerna Pharmaceuticals DRNA:US $ 5.01M 26.25M
Eli Lilly And LLY:US $ 6902.8M 244.2M
Flexion Therapeutics FLXN:US $ 35.23M 4.56M
GlaxoSmithKline GSK:LN 7.51B 324M
Immunogen IMGN:US $ 20.36M 0.68M
Intrexon XON:US $ 26.67M 5.31M
Karyopharm Therapeutics KPTI:US $ 17.89M 44K
Kindred Biosciences KIN:US 1.56M 11.16M
Macrogenics MGNX:US $ 45.25M 38.1M
Mannkind MNKD:US $ 6.3M 2.73M
Newlink Genetics NLNK:US 125K 69K
Novartis NOVN:VX 8.65B 173M
Novavax NVAX:US $ 71.36M 30.83M
Peregrine Pharmaceuticals PPHM:US $ 24.31M 0.64M
Xencor XNCR:US $ 15.32M 9.7M